{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:03:58Z","timestamp":1790521438242,"version":"4.1.0"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,7,1]]},"DOI":"10.1093\/aje\/kwi160","type":"journal-article","created":{"date-parts":[[2005,6,16]],"date-time":"2005-06-16T16:28:30Z","timestamp":1118939310000},"page":"89-100","source":"Crossref","is-referenced-by-count":143,"title":["Dynamic Models of Meningococcal Carriage, Disease, and the Impact of Serogroup C Conjugate Vaccination"],"prefix":"10.1093","volume":"162","author":[{"given":"Caroline L.","family":"Trotter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel J.","family":"Gay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. John","family":"Edmunds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,7,1]]},"reference":[{"key":"key\n\t\t\t\t20171010173715_BIB1","doi-asserted-by":"crossref","unstructured":"Ramsay ME, Andrews N, Kaczmarski EB, et al. Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England. Lancet2001;357:195\u20136.","DOI":"10.1016\/S0140-6736(00)03594-7"},{"key":"key\n\t\t\t\t20171010173715_BIB2","unstructured":"Trotter CL, Ramsay ME, Kaczmarski EB. Meningococcal serogroup C vaccination in England and Wales: coverage and initial impact of the campaign. Commun Dis Public Health2002;5:220\u20135."},{"key":"key\n\t\t\t\t20171010173715_BIB3","doi-asserted-by":"crossref","unstructured":"Maiden MC, Stuart JM: UK Meningococcal Carriage Group. Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination. Lancet2002;359:1829\u201331.","DOI":"10.1016\/S0140-6736(02)08679-8"},{"key":"key\n\t\t\t\t20171010173715_BIB4","doi-asserted-by":"crossref","unstructured":"Ramsay ME, Andrews NJ, Trotter CL, et al. Herd immunity from meningococcal serogroup C conjugate vaccination in England. BMJ2003;326:365\u20136.","DOI":"10.1136\/bmj.326.7385.365"},{"key":"key\n\t\t\t\t20171010173715_BIB5","doi-asserted-by":"crossref","unstructured":"Edmunds WJ, Medley GF, Nokes DJ. Evaluating the cost- effectiveness of vaccination programmes: a dynamic perspective. Stat Med1999;18:3263\u201382.","DOI":"10.1002\/(SICI)1097-0258(19991215)18:23<3263::AID-SIM315>3.0.CO;2-3"},{"key":"key\n\t\t\t\t20171010173715_BIB6","doi-asserted-by":"crossref","unstructured":"Brisson M, Edmunds WJ. Economic evaluation of vaccination programs: the impact of herd immunity. Med Decis Making2003;23:76\u201382.","DOI":"10.1177\/0272989X02239651"},{"key":"key\n\t\t\t\t20171010173715_BIB7","unstructured":"Cartwright K. Meningococcal carriage and disease. In: Cartwright K, ed. Meningococcal disease. Chichester, United Kingdom: John Wiley & Sons, 1995:115\u201346."},{"key":"key\n\t\t\t\t20171010173715_BIB8","doi-asserted-by":"crossref","unstructured":"Goldschneider I, Gotschlich EC, Artenstein MS. Human immunity to the meningococcus. II. Development of natural immunity. J Exp Med1969;129:1327\u201348.","DOI":"10.1084\/jem.129.6.1327"},{"key":"key\n\t\t\t\t20171010173715_BIB9","doi-asserted-by":"crossref","unstructured":"Gold R, Goldschneider I, Lepow ML, et al. Carriage of Neisseria meningitidis and Neisseria lactamica in infants and children. J Infect Dis1978;137:112\u201321.","DOI":"10.1093\/infdis\/137.2.112"},{"key":"key\n\t\t\t\t20171010173715_BIB10","doi-asserted-by":"crossref","unstructured":"Cartwright KA, Stuart JM, Jones DM, et al. The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica. Epidemiol Infect1987;99:591\u2013601.","DOI":"10.1017\/S0950268800066449"},{"key":"key\n\t\t\t\t20171010173715_BIB11","doi-asserted-by":"crossref","unstructured":"Trotter CL, Andrews NJ, Kaczmarski EB, et al. Effectiveness of meningococcal serogroup C conjugate vaccines four years after introduction. Lancet2004;364:365\u20137.","DOI":"10.1016\/S0140-6736(04)16725-1"},{"key":"key\n\t\t\t\t20171010173715_BIB12","doi-asserted-by":"crossref","unstructured":"Borrow R, Goldblatt D, Andrews N, et al. Antibody persistence and immunological memory at age 4 years after meningococcal group C conjugate vaccination in children in the United Kingdom. J Infect Dis2002;186:1353\u20137.","DOI":"10.1086\/344324"},{"key":"key\n\t\t\t\t20171010173715_BIB13","doi-asserted-by":"crossref","unstructured":"Schenzle D. An age-structured model of pre- and post-vaccination measles transmission. IMA J Math Appl Med Biol1984;1:169\u201391.","DOI":"10.1093\/imammb\/1.2.169"},{"key":"key\n\t\t\t\t20171010173715_BIB14","unstructured":"Trotter CL, Gay NJ, Edmunds WJ. The natural history of meningococcal carriage and disease in England and Wales. Epidemiol Infect (in press)."},{"key":"key\n\t\t\t\t20171010173715_BIB15","unstructured":"Anderson RM, May RM. Infectious diseases of humans: dynamics and control. Oxford, United Kingdom: Oxford University Press, 1991."},{"key":"key\n\t\t\t\t20171010173715_BIB16","doi-asserted-by":"crossref","unstructured":"Diekmann O, Heesterbeek JAP, Metz JAJ. On the definition and the computation of the basic reproduction ratio R0 in models for infectious diseases in heterogeneous populations. J Math Biol1990;28:365\u201382.","DOI":"10.1007\/BF00178324"},{"key":"key\n\t\t\t\t20171010173715_BIB17","doi-asserted-by":"crossref","unstructured":"De Wals P, Bouckaert A. Methods for estimating the duration of bacterial carriage. Int J Epidemiol1985;14:628\u201334.","DOI":"10.1093\/ije\/14.4.628"},{"key":"key\n\t\t\t\t20171010173715_BIB18","doi-asserted-by":"crossref","unstructured":"Lansley M, Bedford H. Reflections on the meningococcal group C infection immunisation campaign: views from the sharp end. Vaccine2003;21:2877\u201381.","DOI":"10.1016\/S0264-410X(03)00160-9"},{"key":"key\n\t\t\t\t20171010173715_BIB19","unstructured":"Chief Medical Officer, Chief Nursing Officer, Chief Pharmacist. Extending meningitis C vaccine to 20\u201324 year olds: pneumococcal vaccine for at-risk 2 year olds. Letter published April 1, 2002. (http:\/\/www.dh.gov.uk\/PublicationsAndStatistics\/LettersAndCirculars\/ProfessionalLetters\/ChiefMedicalOfficerLetters\/ChiefMedicalOfficerLettersArticle\/fs\/en?CONTENT_ID=4004730&chk=r2OMzW)."},{"key":"key\n\t\t\t\t20171010173715_BIB20","doi-asserted-by":"crossref","unstructured":"Gay NJ, Hesketh LM, Morgan-Capner P, et al. Interpretation of serological surveillance data for measles using mathematical models: implications for vaccine strategy. Epidemiol Infect1995;115:139\u201356.","DOI":"10.1017\/S0950268800058209"},{"key":"key\n\t\t\t\t20171010173715_BIB21","doi-asserted-by":"crossref","unstructured":"Jodar L, LaForce FM, Ceccarini C, et al. Meningococcal conjugate vaccine for Africa: a model for development of new vaccines for the poorest countries. Lancet2003;361:1902\u20134.","DOI":"10.1016\/S0140-6736(03)13494-0"},{"key":"key\n\t\t\t\t20171010173715_BIB22","doi-asserted-by":"crossref","unstructured":"Bjune G, Hoiby EA, Gronnesby JK, et al. Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway. Lancet1991;338:1093\u20136.","DOI":"10.1016\/0140-6736(91)91961-S"},{"key":"key\n\t\t\t\t20171010173715_BIB23","doi-asserted-by":"crossref","unstructured":"Boslego J, Garcia J, Cruz C, et al. Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile. Vaccine1995;13:821\u20139.","DOI":"10.1016\/0264-410X(94)00037-N"},{"key":"key\n\t\t\t\t20171010173715_BIB24","doi-asserted-by":"crossref","unstructured":"de Kleijn ED, de Groot R, Labadie J, et al. Immunogenicity and safety of a hexavalent meningococcal outer-membrane-vesicle vaccine in children of 2\u20133 and 7\u20138 years of age. Vaccine2000;18:1456\u201366.","DOI":"10.1016\/S0264-410X(99)00423-5"},{"key":"key\n\t\t\t\t20171010173715_BIB25","unstructured":"The evolving meningococcal disease epidemic in New Zealand. N Z Public Health Rep2003;6:57\u201360."},{"key":"key\n\t\t\t\t20171010173715_BIB26","unstructured":"Trotter CL, Ramsay ME, Slack MPE. Rising incidence of Haemophilus influenzae type b disease in England and Wales indicates a need for a second catch-up vaccination campaign. Commun Dis Public Health2003;6:55\u20138."},{"key":"key\n\t\t\t\t20171010173715_BIB27","doi-asserted-by":"crossref","unstructured":"Dietz K. The estimation of the basic reproduction number for infectious diseases. Stat Methods Med Res1993;2:23\u201341.","DOI":"10.1177\/096228029300200103"}],"container-title":["American Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/aje\/article-pdf\/162\/1\/89\/395504\/kwi160.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T19:38:00Z","timestamp":1586288280000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/aje\/article\/162\/1\/89\/166230\/Dynamic-Models-of-Meningococcal-Carriage-Disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7,1]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2005,7,1]]},"published-print":{"date-parts":[[2005,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/aje\/kwi160","relation":{},"ISSN":["1476-6256","0002-9262"],"issn-type":[{"value":"1476-6256","type":"electronic"},{"value":"0002-9262","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,7,1]]},"published":{"date-parts":[[2005,7,1]]}}}